investment

News

AstraZeneca reveals $50bn investment in US facilities

Trump's pharma tariffs haven't appeared yet, but AstraZeneca has joined several of its peers with big investments in US manufacturing and R&D.

News

Choose Europe for Life Sciences campaign image

Pharma welcomes EU push to restore life sciences sector

European pharma trade group EFPIA has said that a strategy launched by the EU to bolster the region's standing in life sciences is a "step forward."

News

Generic drugmaker Hikma pledges $1bn in US investment

With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.

Market Access

Political uncertainties, tariffs, funding crunch? LSX World ...

The weather was hot in London for this year’s LSX World Congress – but what was the atmosphere like at Europe’s leading partnering, strategy, and investment event?

Market Access

VCs upbeat about European life sciences market, despite unce...

It has been a curious start to the year for pharma and biotech investment.

News

UK trumpets £1bn investment plan from BioNTech

BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.

AstraZeneca reveals $50bn investment in US facilities

Pharma welcomes EU push to restore life sciences sector

Generic drugmaker Hikma pledges $1bn in US investment

Political uncertainties, tariffs, funding crunch? LSX World ...

VCs upbeat about European life sciences market, despite unce...

UK trumpets £1bn investment plan from BioNTech

Agios mulls early FDA filing for sickle cell therapy

Using AI-driven synthetic personas to take your insights fur...

investment

Editor's Picks